Compliance in clinical trials.
Open Access
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 48 (10) , 871-875
- https://doi.org/10.1136/ard.48.10.871
Abstract
Compliance with treatment can be an important determinant of the outcome of clinical trials. To date there is no completely satisfactory method of measuring compliance and some of the most widely used methods are inadequate. The various methods of measuring compliance and how they have been applied to clinical trials are described, and improvements in the standard of the measurement and reporting of compliance in clinical trials are suggested.Keywords
This publication has 39 references indexed in Scilit:
- THE USE OF A PHARMACOLOGICAL INDICATOR TO INVESTIGATE COMPLIANCE IN PATIENTS WITH A POOR RESPONSE TO ANTIRHEUMATIC THERAPYRheumatology, 1988
- A General Method of Compliance Assessment Using Centralized Pharmacy RecordsMedical Care, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.Annals of the Rheumatic Diseases, 1986
- DETERMINANTS OF COMPLIANCE IN RHEUMATOID ARTHRITIC PATIENTS ASSESSED IN THEIR HOME ENVIRONMENTRheumatology, 1985
- CIMETIDINE VERSUS RANITIDINEThe Lancet, 1985
- "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.BMJ, 1984
- Do patients cash prescriptions?BMJ, 1982
- Patient non-compliance within the context of seeking medical care for arthritisJournal of Chronic Diseases, 1973
- The Inaccuracy in Using Interviews to Estimate Patient Reliability in Taking Medications at HomeMedical Care, 1969